Reproductive and Sexual Function After Platinum-Based Chemotherapy in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group Study
- 1 July 2007
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (19) , 2792-2797
Abstract
Purpose: To compare malignant ovarian germ cell tumor survivors with a matched control group of females on menstrual and reproductive outcomes, sexual functioning, and dyadic adjustment. Patients and Methods: Eligible patients met the following criteria: (1) history of malignant ovarian germ cell tumor; (2) treatment with surgery plus platinum-based chemotherapy; (3) age at least 18 years and continuously disease-free with minimum follow-up of 2 years; (4) capability of completing questionnaire and telephone interview; and (5) completion of written informed consent. The control group was drawn from acquaintances recommended by survivors and matched for age, race, and education. Scales with established reliability and validity were used to measure quality-of-life concepts of sexual functioning and social networks. Results: One hundred thirty-two survivors and 137 controls completed the study. Of 132 survivors, 71 (53.8%) had fertility-sparing surgery. Of fertile survivors, 62 (87.3%) reported still having menstrual periods. Twenty-four survivors reported 37 offspring after cancer treatment. Compared with controls, survivors had significantly greater reproductive concerns (P < .0001), less sexual pleasure (P = .003), and lower scores on the total Sexual Activity Scale Score (P = .001). However, survivors had better dyadic consensus (P = .004), dyadic satisfaction (P = .005), and dyadic cohesion (P = .014). Conclusion: Women who had fertility-sparing surgery were very likely to retain menstrual function and fertility after chemotherapy. Although there is some increase in gynecologic symptoms and diminution in sexual pleasure, survivors tended to have stronger, more positive relationships with significant others.Keywords
This publication has 34 references indexed in Scilit:
- Quality of life in long-term cervical cancer survivorsGynecologic Oncology, 2005
- Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology GroupGynecologic Oncology, 2004
- Management of malignant ovarian immature teratoma. Role of adriamycinCancer, 1990
- Effects of Treatment on Fertility in Long-Term Survivors of Childhood or Adolescent CancerNew England Journal of Medicine, 1987
- A Confirmatory Analysis of the Dyadic Adjustment ScaleJournal of Marriage and Family, 1982
- CYCLICAL COMBINATION CHEMOTHERAPY AND GONADAL FUNCTIONThe Lancet, 1979
- Measuring Dyadic Adjustment: New Scales for Assessing the Quality of Marriage and Similar DyadsJournal of Marriage and Family, 1976
- Cyclophosphamide and the prepubertal gonad: A negative reportThe Journal of Pediatrics, 1974
- STERILITY AND CYCLOPHOSPHAMIDEThe Lancet, 1972
- Multiple late complications of therapy with cyclophosphamide, including ovarian destructionThe American Journal of Medicine, 1971